Paul Moorehead

433 total citations
30 papers, 285 citations indexed

About

Paul Moorehead is a scholar working on Hematology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Paul Moorehead has authored 30 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Oncology. Recurrent topics in Paul Moorehead's work include Hemophilia Treatment and Research (11 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (6 papers). Paul Moorehead is often cited by papers focused on Hemophilia Treatment and Research (11 papers), Blood Coagulation and Thrombosis Mechanisms (7 papers) and Platelet Disorders and Treatments (6 papers). Paul Moorehead collaborates with scholars based in Canada, United States and United Kingdom. Paul Moorehead's co-authors include Roger Chafe, David Lillicrap, Christine Hough, Birgit M. Reipert, Robert J. Klaassen, Ronald J. Bernardi, Amy D. Shapiro, Christophe Schmitt, Johnny Mahlangu and Nicholas Barrowman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Paul Moorehead

29 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Moorehead Canada 10 155 43 41 36 26 30 285
Hande Kızılocak United States 10 197 1.3× 60 1.4× 22 0.5× 36 1.0× 36 1.4× 19 291
Steven S. Bae Canada 8 181 1.2× 36 0.8× 34 0.8× 8 0.2× 7 0.3× 16 392
Kate Nesbitt Canada 10 187 1.2× 30 0.7× 77 1.9× 15 0.4× 13 0.5× 19 379
Anthony Oyekunle Nigeria 11 192 1.2× 112 2.6× 17 0.4× 11 0.3× 47 1.8× 33 295
Georgia McCaughan Australia 10 86 0.6× 17 0.4× 22 0.5× 12 0.3× 82 3.2× 29 265
Anita J. Kumar United States 11 61 0.4× 20 0.5× 24 0.6× 47 1.3× 95 3.7× 37 245
Campbell Tiley Australia 10 216 1.4× 32 0.7× 78 1.9× 39 1.1× 159 6.1× 25 351
Kimberly Legault Canada 8 81 0.5× 11 0.3× 25 0.6× 5 0.1× 11 0.4× 16 240
C Bender-Götze Germany 8 200 1.3× 23 0.5× 18 0.4× 83 2.3× 39 1.5× 16 268
Khawar Siddiqui Saudi Arabia 12 116 0.7× 62 1.4× 91 2.2× 28 0.8× 74 2.8× 57 358

Countries citing papers authored by Paul Moorehead

Since Specialization
Citations

This map shows the geographic impact of Paul Moorehead's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Moorehead with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Moorehead more than expected).

Fields of papers citing papers by Paul Moorehead

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Moorehead. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Moorehead. The network helps show where Paul Moorehead may publish in the future.

Co-authorship network of co-authors of Paul Moorehead

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Moorehead. A scholar is included among the top collaborators of Paul Moorehead based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Moorehead. Paul Moorehead is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McMullen, Sarah, et al.. (2024). Pediatric pulmonary thromboembolism: a 3-year Canadian Pediatric Surveillance Program study. Journal of Thrombosis and Haemostasis. 22(5). 1366–1371. 2 indexed citations
2.
Peña‐Castillo, Lourdes, et al.. (2023). Extracellular vesicle small RNA cargo discriminates non-cancer donors from pediatric B-lymphoblastic leukemia patients. Frontiers in Oncology. 13. 1272883–1272883. 1 indexed citations
3.
Négrier, Claude, Johnny Mahlangu, Michaela Lehle, et al.. (2023). Emicizumab in people with moderate or mild haemophilia A (HAVEN 6): a multicentre, open-label, single-arm, phase 3 study. The Lancet Haematology. 10(3). e168–e177. 45 indexed citations
4.
Négrier, Claude, Johnny Mahlangu, Michaela Lehle, et al.. (2021). Emicizumab Prophylaxis in Persons with Mild or Moderate Hemophilia A: Results from the Interim Analysis of the HAVEN 6 Study. Blood. 138(Supplement 1). 343–343. 7 indexed citations
5.
6.
7.
Moorehead, Paul, Tongyao Liu, Jennifer Dumont, et al.. (2020). Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor. Frontiers in Immunology. 11. 138–138. 7 indexed citations
8.
Smith, Nicole C., et al.. (2020). Deciphering the messages carried by extracellular vesicles in hematological malignancies. Blood Reviews. 46. 100734–100734. 20 indexed citations
9.
Moorehead, Paul, et al.. (2020). Evaluating a Transition Workbook for Childhood Cancer Survivors: a Pilot Study. Journal of Cancer Education. 37(3). 593–598. 4 indexed citations
10.
Morishita, Kimberly, Paul Dancey, Paul Moorehead, et al.. (2019). Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis. Arthritis & Rheumatology. 71(10). 1747–1755. 38 indexed citations
11.
Moorehead, Paul, et al.. (2019). Standardizing the categorizations of models of aftercare for survivors of childhood cancer. BMC Health Services Research. 19(1). 850–850. 5 indexed citations
12.
Chafe, Roger, et al.. (2018). Interventions to improve the aftercare of survivors of childhood cancer: A systematic review. SHILAP Revista de lepidopterología. 3(4). 90–98. 9 indexed citations
13.
Moorehead, Paul, Alice S. van Velzen, Kate Nesbitt, et al.. (2018). Dexamethasone promotes durable factor VIII-specific tolerance in hemophilia A mice via thymic mechanisms. Haematologica. 103(8). 1403–1413. 9 indexed citations
14.
Kuhle, Stefan, et al.. (2018). The association of venous thromboembolism with survival in pediatric cancer patients: a population-based cohort study. Annals of Hematology. 97(10). 1903–1908. 12 indexed citations
15.
Moorehead, Paul, et al.. (2017). A Prospective Study of the Association Between Clinically Significant Bleeding in PICU Patients and Thrombocytopenia or Prolonged Coagulation Times*. Pediatric Critical Care Medicine. 18(10). e455–e462. 9 indexed citations
16.
Moorehead, Paul, Angie Tuttle, Julie Grabell, et al.. (2014). Rapid Acquisition of Immunologic Tolerance to Factor VIII and Disappearance of Anti-factor VIII IgG4 After Prophylactic Therapy in a Hemophilia A Patient With High-titer Factor VIII Inhibitor. Journal of Pediatric Hematology/Oncology. 37(4). e220–e222. 2 indexed citations
17.
Moorehead, Paul, Jamie Ray, Nicholas Barrowman, Brigitte Lemyre, & Robert J. Klaassen. (2013). A survey of the management of newborns with severe hemophilia in Canada. Paediatrics & Child Health. 18(4). 189–193. 3 indexed citations
18.
Moorehead, Paul. (2013). Travelling Well: Essays in Medical Tourism. Canadian Medical Association Journal. 186(1). E66.1–E66. 11 indexed citations
19.
Moorehead, Paul, et al.. (2012). An evidence-based threshold for thrombocytopenia associated with clinically significant bleeding in pediatric intensive care unit patients*. Pediatric Critical Care Medicine. 13(5). e316–e322. 4 indexed citations
20.
Moorehead, Paul. (2005). A message in search of a method. Canadian Medical Association Journal. 173(7). 789–790.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hande Kızılocak Breakdown of academic impact, for papers by Steven S. Bae Breakdown of academic impact, for papers by Kate Nesbitt Breakdown of academic impact, for papers by Anthony Oyekunle Breakdown of academic impact, for papers by Georgia McCaughan Breakdown of academic impact, for papers by Anita J. Kumar Breakdown of academic impact, for papers by Campbell Tiley Breakdown of academic impact, for papers by Kimberly Legault Breakdown of academic impact, for papers by C Bender-Götze Breakdown of academic impact, for papers by Khawar Siddiqui
Rankless by CCL
2026